HeXun Biosciences Co (ROCO:6986) Net Margin %: 43.37% (As of Dec. 2025) — 36% Above Median


ROCO:6986 HeXun Biosciences Co Ltd ROCO:6986
23 GF Score
Price NT$47.00
! 1 Warning Sign
View Full Analysis

What is HeXun Biosciences Co Net Margin %?

HeXun Biosciences Co ROCO:6986 23 Net Margin % is 43.37% as of Dec. 2025, which is 36% above its 10-year median of 31.91. GuruFocus rates ROCO:6986 with a GF Score™ of 23/100. The stock has 1 warning sign investors should review. Among 941 Biotechnology companies, HeXun Biosciences Co ranks better than 92.45% on this metric.

Net margin is calculated as Net Income divided by its Revenue. HeXun Biosciences Co's Net Income for the three months ended in Dec. 2025 was NT$37.0 Mil. HeXun Biosciences Co's Revenue for the three months ended in Dec. 2025 was NT$85.3 Mil. Therefore, HeXun Biosciences Co's net margin for the quarter that ended in Dec. 2025 was 43.37%.

The historical rank and industry rank for HeXun Biosciences Co's Net Margin % or its related term are showing as below:

ROCO:6986' s Net Margin % Range Over the Past 10 Years
Min: -10.49   Med: 31.91   Max: 51.4
Current: 35.64

ROCO:6986's Net Margin % is ranked better than
92.45% of 941 companies
in the Biotechnology industry
Industry Median: -88.29 vs ROCO:6986: 35.64

HeXun Biosciences Co  (ROCO:6986) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

HeXun Biosciences Co Net Margin % Related Terms

HeXun Biosciences Co Net Margin % Historical Data

* Premium members only.

The historical data trend for HeXun Biosciences Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeXun Biosciences Co Net Margin % Chart

HeXun Biosciences Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial 0.00 -10.49 25.65 51.40 38.16

HeXun Biosciences Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 46.41 45.11 0.00 23.99 43.37

ROCO:6986 vs VRTX, REGN, ALNY: Net Margin % Comparison

For the Biotechnology subindustry, HeXun Biosciences Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeXun Biosciences Co Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HeXun Biosciences Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where HeXun Biosciences Co's Net Margin % falls into.


ROCO:6986
23GF Score
HeXun Biosciences Co Ltd ROCO:6986
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeXun Biosciences Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

HeXun Biosciences Co's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=111.906/293.225
=38.16 %

HeXun Biosciences Co's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=36.977/85.258
=43.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 43.37% mean?
HeXun Biosciences Co (ROCO:6986) has a Net Margin % of 43.37% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on HeXun Biosciences Co and its competitors. This is 36% above median its historical median of 31.91. According to the industry distribution chart, HeXun Biosciences Co ranks #71 out of 941 companies in the Biotechnology industry, placing it in the top 7.5%.
Is HeXun Biosciences Co's Net Margin % too high?
HeXun Biosciences Co's current Net Margin % of 43.37% is 36% above median its 10-year median of 31.91. Based on the distribution chart, HeXun Biosciences Co ranks #71 out of 941 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, HeXun Biosciences Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does HeXun Biosciences Co's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, HeXun Biosciences Co ranks #71 out of 941 companies for Net Margin %. This places HeXun Biosciences Co in the top 8% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on HeXun Biosciences Co and its competitors. HeXun Biosciences Co's current Net Margin % is 43.37%, which is 36% above median its own 10-year median of 31.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeXun Biosciences Co stock overvalued right now?
HeXun Biosciences Co (ROCO:6986) has a current Net Margin % of 43.37%. The current Net Margin % is 43.37%, which is 36% above median its 10-year median of 31.91. HeXun Biosciences Co's overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For HeXun Biosciences Co (ROCO:6986), the current Net Margin % is 43.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

HeXun Biosciences Co Business Description

Address Chunri Road, 6 F., No. 1490, Taoyuan District, Taoyuan, TWN
HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.
23GF Score

Get the complete analysis for ROCO:6986

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$47.00
Price